Please use this identifier to cite or link to this item:
https://doi.org/10.21256/zhaw-23574Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Altwicker-Hámori, Szilvia | - |
| dc.contributor.author | Juvalta, Sibylle | - |
| dc.contributor.author | Bargetzi, Mario | - |
| dc.contributor.author | Renner, Christoph | - |
| dc.contributor.author | Taverna, Christina | - |
| dc.contributor.author | Dratva, Julia | - |
| dc.date.accessioned | 2021-11-29T09:38:52Z | - |
| dc.date.available | 2021-11-29T09:38:52Z | - |
| dc.date.issued | 2021-11-18 | - |
| dc.identifier.issn | 2504-1622 | de_CH |
| dc.identifier.uri | https://digitalcollection.zhaw.ch/handle/11475/23574 | - |
| dc.description.abstract | Background: Medication beliefs have been found to be associated with medication adherence among various cancer patients. Despite its importance, medication beliefs have not been investigated in patients with multiple myeloma (MM). A study on quality of life in MM patients provided the opportunity to fill this gap. Methods: Patients were recruited consecutively from three Swiss oncology/hematology centres. Inclusion criteria included confirmed histological MM diagnosis, age ≥18 years and informed consent. Exclusion criteria were participation in another clinical study, inability to communicate in German and more than one cancer diagnosis. Participants completed a survey including the Beliefs about Medicines Questionnaire (BMQ) and a sociodemographic questionnaire. Clinical data was extracted from medical records. The complete case dataset (N = 41) was analysed using descriptive statistical methods. Results: Most participants were men (59%), married/partnered (80%), born in Switzerland (80%), economically inactive (85%) and completed at most upper secondary education (72%). Mean age at diagnosis was 61 years (range: 35-81 years). 48% of the participants were in a stable/plateau phase, 37% in a relapsed/progressive phase and 15% newly diagnosed; 96% had good ECOG performance status. Table 1 presents the results of the BMQ. The vast majority of the sample believed in the necessity of their medication for maintaining their health; however, 70% reported concerns about their long-term effects. The specific-necessity subscale and general-harm subscale showed the highest and lowest mean, respectively. Conclusions: The results indicate higher necessity beliefs than concerns towards MM medication. Specific items point to topics to be raised by treating physicians. | de_CH |
| dc.language.iso | en | de_CH |
| dc.publisher | EMH Swiss Medical Publishers | de_CH |
| dc.relation.ispartof | Swiss Medical Weekly | de_CH |
| dc.rights | http://creativecommons.org/licenses/by-nc-sa/4.0/ | de_CH |
| dc.subject.ddc | 616: Innere Medizin und Krankheiten | de_CH |
| dc.title | Beliefs about medicines in patients with multiple myeloma in Switzerland | de_CH |
| dc.type | Konferenz: Poster | de_CH |
| dcterms.type | Text | de_CH |
| zhaw.departement | Gesundheit | de_CH |
| zhaw.departement | School of Management and Law | de_CH |
| zhaw.organisationalunit | Institut für Public Health (IPH) | de_CH |
| zhaw.organisationalunit | Winterthurer Institut für Gesundheitsökonomie (WIG) | de_CH |
| dc.identifier.doi | 10.4414/smw.2021.w30107 | de_CH |
| dc.identifier.doi | 10.21256/zhaw-23574 | - |
| zhaw.conference.details | 4th Swiss Oncology & Hematology Congress (SOHC), Zurich, 18-20 November 2021 | de_CH |
| zhaw.funding.eu | No | de_CH |
| zhaw.issue | Supplementum 255 | de_CH |
| zhaw.originated.zhaw | Yes | de_CH |
| zhaw.pages.end | 29 | de_CH |
| zhaw.pages.start | 28 | de_CH |
| zhaw.publication.status | publishedVersion | de_CH |
| zhaw.volume | 151 | de_CH |
| zhaw.publication.review | Peer review (Abstract) | de_CH |
| zhaw.funding.zhaw | Lebensqualität bei Myelom Patientinnen und Patienten in drei Schweizer Kliniken | de_CH |
| zhaw.author.additional | No | de_CH |
| zhaw.display.portrait | Yes | de_CH |
| Appears in collections: | Publikationen Gesundheit Publikationen School of Management and Law | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2021_AltwickerHamori-etal_Beliefs-about-medicine-myeloma-patients-CH.pdf | 155.8 kB | Adobe PDF |  View/Open |
Show simple item record
Altwicker-Hámori, S., Juvalta, S., Bargetzi, M., Renner, C., Taverna, C., & Dratva, J. (2021). Beliefs about medicines in patients with multiple myeloma in Switzerland [Conference poster]. Swiss Medical Weekly, 151(Supplementum 255), 28–29. https://doi.org/10.4414/smw.2021.w30107
Altwicker-Hámori, S. et al. (2021) ‘Beliefs about medicines in patients with multiple myeloma in Switzerland’, in Swiss Medical Weekly. EMH Swiss Medical Publishers, pp. 28–29. Available at: https://doi.org/10.4414/smw.2021.w30107.
S. Altwicker-Hámori, S. Juvalta, M. Bargetzi, C. Renner, C. Taverna, and J. Dratva, “Beliefs about medicines in patients with multiple myeloma in Switzerland,” in Swiss Medical Weekly, Nov. 2021, vol. 151, no. Supplementum 255, pp. 28–29. doi: 10.4414/smw.2021.w30107.
ALTWICKER-HÁMORI, Szilvia, Sibylle JUVALTA, Mario BARGETZI, Christoph RENNER, Christina TAVERNA und Julia DRATVA, 2021. Beliefs about medicines in patients with multiple myeloma in Switzerland. In: Swiss Medical Weekly. Conference poster. EMH Swiss Medical Publishers. 18 November 2021. S. 28–29
Altwicker-Hámori, Szilvia, Sibylle Juvalta, Mario Bargetzi, Christoph Renner, Christina Taverna, and Julia Dratva. 2021. “Beliefs About Medicines in Patients with Multiple Myeloma in Switzerland.” Conference poster. In Swiss Medical Weekly, 151:28–29. EMH Swiss Medical Publishers. https://doi.org/10.4414/smw.2021.w30107.
Altwicker-Hámori, Szilvia, et al. “Beliefs About Medicines in Patients with Multiple Myeloma in Switzerland.” Swiss Medical Weekly, vol. 151, no. Supplementum 255, EMH Swiss Medical Publishers, 2021, pp. 28–29, https://doi.org/10.4414/smw.2021.w30107.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.